Evotec SE
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| EVT.DE | NOVARTIND.BO | ALVO | 0MTD.IL | EMCURE.BO | EVMN | |
|---|---|---|---|---|---|---|
| Market cap | 532.02M | 42.46B | 1.67B | 178.69B | 424.98B | 219.20M |
| P/E (TTM) | — | 43.4 | — | 50.8 | 38.9 | — |
| Forward P/E | -7.2 | — | 20.3 | — | 27.9 | -1.7 |
| Price/book | 0.8 | 5.2 | -8.7 | 5.2 | 8.0 | 0.8 |
| Dividend yield | — | — | — | — | 0.17% | — |
| 1-year change | −50.40% | +106.60% | −7.71% | +46.92% | +59.82% | −70.14% |
| Today | +3.74% | +0.09% | +2.86% | +2.36% | +3.02% | +1.68% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All EVT.DE news ›RBC leaves Evotec at 'Outperform' - price target 10 euros
Canada's RBC bank has kept its rating on Evotec at Outperform with a price target of €10 following preliminary quarterly results. Revenue and operating profit came in above market expectations,... NEW YORK (dpa-AFX Broker) - Canada's…
Evotec SE Announces Appointment of Joanna Holbrook as Chief Scientific Officer and Member of the Management Board, Effective November 1, 2026
Evotec SE announced the appointment of Dr. Joanna Holbrook as Chief Scientific Officer and Member of the Management Board, effective November 1, 2026. Dr. Holbrook brings to Evotec more than 25 years... Evotec SE announced the appointment…
RBC cuts target for Evotec to €5 - "Speculative Risk"
Canadian bank RBC cut its price target for Evotec to €5 from €10 after adjusting its valuation model ahead of the final results, but left its rating at Outperform. In a comment released... NEW YORK (dpa-AFX Broker) - Canadian…
EQS-News: Evotec SE to Announce Results for the First Nine Months 2026 on November 5, 2026
Investiere jetzt bei unserem Broker finanzen.net ZERO ab 0 € Ordergebühr (zzgl. Spreads). Wir unterstützen dich vom Research bis zur Order. EQS-News: EVOTEC SE / Key word(s): Miscellaneous Evotec SE to Announce Results for the First Nine…
More from 1 other outlet
Forge & Evotec Expand Strategic Alliance With Launch Of BLACKSMITH Platform To Discover Novel Metalloenzyme Inhibitors Across Broad Therapeutic Areas
SAN DIEGO, Oct. 17, 2017 /PRNewswire/ -- Forge Therapeutics, Inc. (Forge) announced today that the companies have expanded their existing strategic alliance and launched the BLACKSMITH platform to ... SAN DIEGO, Oct. 17, 2017 /PRNewswire/…
Evotec (OTCMKTS:EVTCY) Stock Price Breaks Below Fifty Day Moving Average – Here’s What Happened
Posted by Defense World Staff on Oct 20th, 2026 Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $1.74 and traded as low as $1.38. Evotec…
Evotec fills CSO vacancy; Sibylla and AL-S Pharma name new CEOs
Every Friday, The Leadership Edit follows people taking new roles across European biotech and what their moves may tell us about the companies they join. This week: a swift scientific leadership change at Evotec, a broader reshuffle at…
Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
15.10.2026 / 13:38 CET/CEST Legal entity: Government of Abu DhabiCity of registered office, country: Abu Dhabi, United Arab Emirates The stake was held
Evotec SE shareholder sells 11.5M shares in exit
A €2.5109-per-share block trade ends an investment in Evotec SE (EVO). Stock Titan - [SCHEDULE 13D/A] Evotec SE Amended Major Shareholder Report Evotec SE shareholder sells 11.5M shares in exit Three reporting persons ceased to be…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com12
- stocktitan.net5
- prnewswire.com3
- tradingview.com2
- defenseworld.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 27 articles, not a forecast.